Table 3.
The IC50 (µM) and 95% confidence intervals (in parenthesis) of selected compounds for inhibiting transcriptional activation by exogenous human Gli1 or ΔNGli229 in C3H10T1/2 cells 24 h after addition of the test compound (Figure 8).
Gli1 | Gli2 | |
---|---|---|
36 | 11.4 (7.5 – 17.5) | 35.2 (17.8 – 59.9) |
50 | 11.4 (7.9 – 16.3) | 29.4 (2.9 – 66.6) |
63 | 6.9 (6.1 – 7.8) | 23.9 (12.3 – 49.0) |
65 | 9.4 (6.40 – 15.4) | 20.5 (9.2 – 30.9) |